Jul 04, 2026
By Transpire Insight
Description
According to a research report published by Transpire Insight, The Global Catheter Market Size is projected to Grow from USD 38.50 Billion in 2026 to USD 79.21 Billion by 2035, at a CAGR of 9.55 % during the forecast period 2026-2035. The increase in the use of catheters is being fueled by the rise in the incidences of cardiovascular diseases, urinary disorders, diabetes, kidney disease, and neurological problems, apart from the rising preference for minimally invasive procedures. The rising adoption of sophisticated interventional cardiology procedures, increasing use of antimicrobial and coated catheters, developments in catheter technology, and expansion of healthcare facilities are some other factors that are contributing to the growth of the market. Furthermore, the rising geriatric population, hospitalizations, and investments in R&D of medical devices are likely to augment the usage of catheters globally.
Introduction
The Catheter Market is experiencing robust growth because of the rising incidences of cardiovascular disorders, urinary disorders, diabetes, chronic kidney diseases, and the use of minimally invasive surgical procedures. Growing need for complex interventions in interventional cardiology, technological advancements in antimicrobial and coated catheters, and development of healthcare infrastructure are contributing towards market growth. Moreover, aging population across the globe, increased hospitalizations, positive reimbursement policies, and continuous investment in the development of medical devices are anticipated to present lucrative growth prospects for the Catheter Market.
Recent Development News
May 2025: Medtronic posted excellent progress in its cardiac division and emphasized ongoing success with the Affera™ pulsed field ablation (PFA) catheter platform, indicating growing use of advanced electrophysiology catheters.
March 2025: Boston Scientific revealed that it would acquire SoniVie for expanding its portfolio in cardiovascular interventions, which includes the use of catheters to deliver renal denervation solutions in hypertension patients.
Stay Ahead of Emerging Opportunities with Expert Market Insights by Transpire Insight
The results presented through the medium of this blog have been obtained through extensive market research conducted by Transpire Insight, which is a trustworthy advisory firm for many of the leading companies around the world. The reports that we offer are the results of extensive analysis and projections along with specific industry details that enable decision-makers to identify possible areas where there may be scope for development in the fast-evolving industries. The customers who need market segmentation, competitor analysis, regional point of view and projections regarding future investments would greatly gain from the comprehensive report.
Download the exclusive Catheter Market sample report today to uncover expert insights, emerging trends, and the opportunities defining the future of the industry.
Catheter Market Size & Statistics
Regional Growth and Demand Analysis by Transpire Insight:
North America dominates the Catheter Market, occupying 41% of the total market share. The market dominance of North America has been primarily attributed to high incidences of heart diseases, diabetes, urinary problems, and chronic kidney disease in the region, which has resulted in an increase in the demand for procedures using catheters. The availability of technologically advanced healthcare facilities, hospitals, ambulatory surgical centers, favorable reimbursement policies, and adoption of minimally invasive surgeries have played a crucial role in boosting the market growth. Besides, the presence of leading medical device companies and technological advancements in coating and antimicrobial catheters also contributes to the dominance of North America.
It is anticipated that Asia-Pacific will be the leading regional market for the forecasted period because of high health care spending, aging populations, prevalence of chronic disorders, and increasing availability of advanced medical facilities. China, India, Japan, and South Korea are experiencing remarkable growth in hospitals, interventional cardiology, and urology sectors. Health care improvement efforts by the government, growth in the number of patients opting for medical tourism, and the growing awareness of minimally invasive therapies are driving the uptake of advanced catheter technology.
Top 15 Trends in the Catheter Market
Proceed to Checkout to purchase the exclusive Catheter Market report and gain instant access to in-depth market intelligence, strategic analysis, and future growth opportunities.
Minimally invasive procedures are becoming the preferred treatment option for cardiovascular, urological, and neurovascular disorders due to reduced surgical trauma, shorter hospital stays, and faster patient recovery. Catheters play a critical role in these interventions by enabling precise access to targeted anatomical sites. The growing preference for minimally invasive therapies among healthcare providers is significantly driving demand for advanced catheter technologies worldwide.
Healthcare providers are increasingly adopting antimicrobial and infection-resistant catheters to reduce the risk of catheter-associated infections, particularly urinary tract infections (CAUTIs) and bloodstream infections (CRBSIs). Manufacturers are developing catheters with antimicrobial coatings, silver alloys, and advanced surface technologies that inhibit bacterial growth, improve patient safety, and reduce healthcare-associated complications.
Drug-coated catheters are gaining popularity in cardiovascular and peripheral vascular interventions because they help prevent restenosis and improve long-term treatment outcomes. Specialty catheters designed for electrophysiology, neurovascular procedures, and structural heart interventions are also expanding rapidly as physicians seek more precise, disease-specific treatment solutions that improve procedural efficiency and clinical success rates.
Smart catheters equipped with sensors are transforming interventional medicine by providing real-time monitoring of pressure, blood flow, temperature, and other physiological parameters during procedures. These intelligent devices improve procedural accuracy, enable better clinical decision-making, and enhance patient safety. Continued advancements in digital healthcare technologies are accelerating the adoption of sensor-enabled catheter systems.
The increasing prevalence of cardiac arrhythmias, particularly atrial fibrillation, is driving strong demand for electrophysiology and cardiac ablation catheters. Advanced radiofrequency, cryoablation, and pulsed field ablation (PFA) catheter technologies are improving treatment precision while reducing complications. Continuous innovation and expanding clinical indications are making cardiac ablation one of the fastest-growing segments of the catheter market.
The growing incidence of stroke, cerebral aneurysms, and other neurovascular disorders is fueling demand for highly specialized neurovascular catheters. These devices enable minimally invasive procedures such as thrombectomy, embolization, and aneurysm repair with greater precision and reduced patient risk. Ongoing technological advancements in catheter flexibility, navigation, and imaging compatibility are further supporting growth in neurovascular interventions.
Top 25 Companies Leading the Catheter Market
Customize the exclusive Catheter Market report today to receive tailored insights, country-specific analysis, and business-focused market intelligence.
Medtronic Plc is an internationally recognized company in the manufacture of various types of medical devices and therapies. Medtronic is one of the pioneers in the creation of innovative medical products and therapies in the field of cardiovascular, neuroscience, medical surgery, and diabetic therapy.
Founded: 1949 | Headquarters: Galway, Ireland
Why It Ranks:
Medtronic is ranked amongst the top globally owing to its diversified catheter product line, consistent innovation in minimally invasive medical devices, and its strong position in both cardiovascular and electrophysiology operations.
Regional Dominance:
North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa regions.
Product Line:
Electrophysiology catheters, ablation catheters, vascular catheters, neurovascular catheters, cardiac mapping systems, and interventional cardiology.
Recent Development:
In 2025, Medtronic enhanced its electrophysiology portfolio by innovating the pulsed field ablation catheter platform and cardiac mapping devices.
Boston Scientific Corporation is an international provider of medical devices based in Marlborough. Its areas of expertise include cardiovascular intervention, electrophysiology, endoscopy, peripheral interventions, and urology.
Founded: 1979 | Headquarters: Marlborough, Massachusetts, USA
Why It Ranks:
This company ranks highly because of its broad catheter range, strong performance in cardiovascular sector, and consistent investments in catheter-based minimally invasive procedures.
Regional Dominance:
North America, Europe, Asia-Pacific, Latin America, and the Middle East.
Product Line:
Catheters for ablation, angiography, intravascular ultrasound (IVUS), electrophysiology, urology, and peripheral intervention devices.
Recent Development:
In 2025, Boston Scientific Corporation strengthened its cardiovascular catheter line with new acquisitions and developments of intracardiac imaging catheter technology.
Abbott Laboratories is a multinational healthcare organization with headquarters in Abbott Park. This healthcare company manufactures medical devices, diagnostic solutions, nutrition products, and prescription drugs and has extensive operations within the field of cardiac care.
Founded: 1888 | Headquarters: Abbott Park, Illinois, USA
Why It Ranks:
Abbott Laboratories is well-known for its innovative approach in the fields of interventional cardiology, structural heart therapy, and catheter technology.
Regional Dominance:
North America, Europe, Asia-Pacific, Latin America, and Africa.
Product Line:
Coronary catheters, guide catheters, electrophysiology catheters, vascular access catheters, and systems for structural heart interventions.
Recent Development:
In 2025, Abbott Labs expanded its electrophysiology and cardiovascular catheter product line by launching innovative technology-driven products.
Becton, Dickinson and Company (BD) is a global medtech company with headquarters located in Franklin Lakes. The firm is one of the major producers of vascular access solutions, infusion therapy, and catheter solutions.
Founded: 1897 | Headquarters: Franklin Lakes, New Jersey, USA
Why It Ranks:
The company ranks as one of the leading catheter companies because of the wide range of its vascular access solutions, infection prevention products, and overall presence in global healthcare.
Regional Dominance:
North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.
Product Line:
Peripheral intravenous catheters, central venous catheters, urinary catheters, infusion catheters, and vascular access solutions.
Recent Development:
In 2025, BD continued its work on improving vascular access technologies by concentrating on patient safety and infection prevention.
Terumo Corporation is a Japanese company that operates in the medical technology industry, with its headquarters located in Tokyo. The company has expertise in cardiovascular intervention, vascular grafts, neurovascular devices, and catheter systems.
Founded: 1921 | Headquarters: Tokyo, Japan
Why It Ranks:
Terumo is known for its innovative guidewire and catheter technologies utilized in cardiovascular, neurovascular, and peripheral intervention procedures.
Regional Dominance:
Asia-Pacific, North America, Europe, and Latin America.
Product Line:
Guide catheters, angiography catheters, neurovascular catheters, vascular access devices, guidewires, and interventional systems.
Recent Development:
The company developed advanced catheter technologies in 2025 for complex cardiovascular and neurovascular procedures.
Teleflex Incorporated is a multinational manufacturer of medical devices with headquarters in Wayne. They manufacture vascular access, anesthesia, surgical, urological, and interventional cardiology products.
Founded: 1943 | Headquarters: Wayne, Pennsylvania, USA
Why It Ranks:
It scores high because of its strong vascular access and specialty catheter product line and continual development of minimally invasive devices.
Regional Dominance:
North America, Europe, Asia Pacific, Latin America, and Middle East.
Product Line:
Central Venous Catheters, PICC Lines, Arterial Catheters, Urology Catheters, Hemodialysis Catheters, and Vascular Access Systems.
Recent Development:
In 2025, Teleflex added to their vascular access product line with products designed to increase procedural efficiency and patient safety.
Cook Medical is a privately-owned medical equipment company whose headquarters are in Bloomington. This firm designs and manufactures minimally invasive catheters and other devices used in vascular intervention, urology, gastroenterology, and critical care.
Founded: 1963 | Headquarters: Bloomington, Indiana, USA
Why It Ranks:
Cook Medical has earned itself recognition for designing a large variety of specialty catheters and minimally invasive therapeutic devices in various branches of medicine.
Regional Dominance:
North America, Europe, Asia-Pacific, and Latin America.
Product Line:
Drainage Catheters, Angiographic Catheters, Embolization Catheters, Urology Catheters, Biliary Catheters, and Critical Care Devices.
Recent Development:
In 2025, Cook Medical continued to develop new minimally invasive catheters and devices for vascular and urological procedures.
Braun SE is a multinational healthcare and pharmaceutical organization based in Melsungen. The firm makes products in areas such as infusion therapy, surgical procedures, anesthesia, and vascular access.
Founded: 1839 | Headquarters: Melsungen, Germany
Why It Ranks:
The firm is one of the best catheter producers because of its wide range of infusion therapies and sophisticated vascular access technologies.
Regional Dominance:
Europe, North America, Asia-Pacific, Latin America, and Africa.
Product Line:
Intravenous catheters, urinary catheters, central venous catheters, infusion sets, dialysis catheters, and anesthesia devices.
Recent Development:
In 2025, B. Braun improved its vascular access products through the introduction of infection prevention technologies and novel catheter systems.
Edwards Lifesciences Corporation is an international firm that deals with medical technology, based out of Irvine.
Founded: 1958 | Headquarters: Irvine, California, USA
Why It Ranks:
Edwards Lifesciences is one of the leading firms in structural heart interventions backed up with highly advanced transcatheter technologies.
Regional Dominance:
North America, Europe, Asia-Pacific, and Latin America.
Product Line:
Transcatheter heart valves, hemodynamic monitoring catheters, critical care catheters, and cardiovascular intervention devices.
Recent Development:
Edwards Lifesciences in 2025 further developed its transcatheter heart therapies for structural heart disease management.
Cardinal Health, Inc. is a multinational corporation that provides health services and medical products to the healthcare industry. It offers a wide range of medical devices and catheter products to hospitals and other health organizations.
Founded: 1971 | Headquarters: Dublin, Ohio, USA
Why It Ranks:
Cardinal Health ranks among top companies because of the wide distribution network, extensive list of medical products, and dominance in vascular access products and catheter products.
Regional Dominance:
North America with international operations on the rise.
Product Line:
Urinary catheters, vascular access catheters, intravenous catheters, catheter kits, medical disposables, and infection prevention products.
Recent Development:
In 2025, Cardinal Health will be expanding its medical products list with advanced supply chain management and catheter products for acute care settings.
Schedule a meeting with our market experts to discuss the exclusive Catheter Market report and identify the best research solution for your organization.
Conclusion
The Catheter Market has been growing at a rapid pace, primarily because of the rise in incidence of diseases like cardiovascular diseases, urological diseases, and neurological diseases, increase in demand for minimally invasive surgeries, and innovations in catheters. The developments taking place in catheters today include antimicrobial coating catheters, drug-coated catheters, sensing catheters, and robotic navigation catheters. Companies dominating the catheter market include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Becton, Dickinson and Company, Terumo Corporation, Teleflex Incorporated, Cook Medical, B. Braun SE, Edwards Lifesciences Corporation, and Cardinal Health, Inc. They are focusing on innovation, acquisitions, and international expansion to strengthen their market position. Going forward, considering the focus of the health care system on minimally invasive procedures and investment in medical technology, the catheter market will continue to grow at a robust rate in the long run.
Send us a brief description of your challenge and we'll get back to you within 24 hours.
inquiry@transpireinsight.com
APAC:+91 7666513636
Address
